Enfusion, Inc. (NYSE:ENFN – Get Rating) was the recipient of a significant decline in short interest in the month of March. As of March 31st, there was short interest totalling 1,280,000 shares, a decline of 9.2% from the March 15th total of 1,410,000 shares. Based on an average daily trading volume, of 399,900 shares, the […]
Piper Sandler began coverage on shares of Enfusion (NYSE:ENFN – Get Rating) in a research report report published on Monday, The Fly reports. The brokerage issued a neutral rating and a $11.00 price target on the stock. The analysts noted that the move was a valuation call. A number of other research firms also recently […]
Piper Sandler initiated coverage on shares of Enfusion (NYSE:ENFN – Get Rating) in a research note issued to investors on Monday morning, The Fly reports. The brokerage issued a neutral rating and a $11.00 price objective on the stock. The analysts noted that the move was a valuation call. A number of other research firms […]
Enfusion, Inc. (NYSE:ENFN – Get Rating) CTO Dan Groman sold 3,877 shares of the business’s stock in a transaction dated Friday, March 17th. The shares were sold at an average price of $10.94, for a total value of $42,414.38. Following the sale, the chief technology officer now directly owns 85,979 shares of the company’s stock, […]